Prevalence and variability of current depressive disorder in 27 European countries: a population-based study

BACKGROUND: We aimed to estimate the prevalence of current depressive disorder in 27 European countries, and to explore differences in prevalence between European countries and by gender. METHODS: In this population-based study, we analysed data from respondents living in 27 European countries who w...

Full description

Bibliographic Details
Published in:The Lancet Public Health
Main Authors: Arias-de la Torre, Jorge, Vilagut, Gemma, Ronaldson, Amy, Serrano-Blanco, Antoni, Martín, Vicente, Peters, Michele, Valderas, Jose M, Dregan, Alex, Alonso, Jordi
Format: Text
Language:English
Published: Elsevier, Ltd 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452/
http://www.ncbi.nlm.nih.gov/pubmed/33961802
https://doi.org/10.1016/S2468-2667(21)00047-5
id ftpubmed:oai:pubmedcentral.nih.gov:8460452
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8460452 2023-05-15T16:52:42+02:00 Prevalence and variability of current depressive disorder in 27 European countries: a population-based study Arias-de la Torre, Jorge Vilagut, Gemma Ronaldson, Amy Serrano-Blanco, Antoni Martín, Vicente Peters, Michele Valderas, Jose M Dregan, Alex Alonso, Jordi 2021-05-04 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452/ http://www.ncbi.nlm.nih.gov/pubmed/33961802 https://doi.org/10.1016/S2468-2667(21)00047-5 en eng Elsevier, Ltd http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452/ http://www.ncbi.nlm.nih.gov/pubmed/33961802 http://dx.doi.org/10.1016/S2468-2667(21)00047-5 © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). CC-BY Lancet Public Health Articles Text 2021 ftpubmed https://doi.org/10.1016/S2468-2667(21)00047-5 2021-10-03T00:46:35Z BACKGROUND: We aimed to estimate the prevalence of current depressive disorder in 27 European countries, and to explore differences in prevalence between European countries and by gender. METHODS: In this population-based study, we analysed data from respondents living in 27 European countries who were included in the second wave of the European Health Interview Survey, collected between 2013 and 2015. We assessed the prevalence of current depressive disorder using the eight-item Patient Health Questionnaire (PHQ-8), with depressive disorder defined as a PHQ-8 score of 10 or higher. Prevalence estimates and 95% CIs were calculated for all 27 countries overall and for each country individually. We assessed variation in prevalence (country vs the rest of Europe) using crude and adjusted prevalence ratios obtained from negative binomial regression models. We did all analyses for the total sample and stratified by gender. FINDINGS: Our analysis sample comprised 258 888 individuals, of whom 117 310 (weighted proportion 47·8%) were men and 141 578 (52·2%) were women. The overall prevalence of current depressive disorder was 6·38% (95% CI 6·24–6·52) with important variation across countries, ranging from 2·58% (2·14–3·02) in the Czech Republic to 10·33% (9·33–11·32) in Iceland. Prevalence was higher in women (7·74% [7·53–7·95]) than in men (4·89% [4·71–5·08]), with clear gender differences for all countries except Finland and Croatia. Compared with the other European countries in our sample, those with the highest adjusted prevalence ratios were Germany (1·80 [1·71–1·89]) and Luxembourg (1·50 [1·35–1·66]), and those with the lowest adjusted prevalence ratios were Slovakia (0·28 [0·24–0·33]) and the Czech Republic (0·32 [0·27–0·38]). INTERPRETATION: Depressive disorders, although common across Europe, vary substantially in prevalence between countries. These results could be a baseline for monitoring the prevalence of current depressive disorder both at a country level in Europe and for planning health-care resources ... Text Iceland PubMed Central (PMC) The Lancet Public Health 6 10 e729 e738
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Articles
spellingShingle Articles
Arias-de la Torre, Jorge
Vilagut, Gemma
Ronaldson, Amy
Serrano-Blanco, Antoni
Martín, Vicente
Peters, Michele
Valderas, Jose M
Dregan, Alex
Alonso, Jordi
Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
topic_facet Articles
description BACKGROUND: We aimed to estimate the prevalence of current depressive disorder in 27 European countries, and to explore differences in prevalence between European countries and by gender. METHODS: In this population-based study, we analysed data from respondents living in 27 European countries who were included in the second wave of the European Health Interview Survey, collected between 2013 and 2015. We assessed the prevalence of current depressive disorder using the eight-item Patient Health Questionnaire (PHQ-8), with depressive disorder defined as a PHQ-8 score of 10 or higher. Prevalence estimates and 95% CIs were calculated for all 27 countries overall and for each country individually. We assessed variation in prevalence (country vs the rest of Europe) using crude and adjusted prevalence ratios obtained from negative binomial regression models. We did all analyses for the total sample and stratified by gender. FINDINGS: Our analysis sample comprised 258 888 individuals, of whom 117 310 (weighted proportion 47·8%) were men and 141 578 (52·2%) were women. The overall prevalence of current depressive disorder was 6·38% (95% CI 6·24–6·52) with important variation across countries, ranging from 2·58% (2·14–3·02) in the Czech Republic to 10·33% (9·33–11·32) in Iceland. Prevalence was higher in women (7·74% [7·53–7·95]) than in men (4·89% [4·71–5·08]), with clear gender differences for all countries except Finland and Croatia. Compared with the other European countries in our sample, those with the highest adjusted prevalence ratios were Germany (1·80 [1·71–1·89]) and Luxembourg (1·50 [1·35–1·66]), and those with the lowest adjusted prevalence ratios were Slovakia (0·28 [0·24–0·33]) and the Czech Republic (0·32 [0·27–0·38]). INTERPRETATION: Depressive disorders, although common across Europe, vary substantially in prevalence between countries. These results could be a baseline for monitoring the prevalence of current depressive disorder both at a country level in Europe and for planning health-care resources ...
format Text
author Arias-de la Torre, Jorge
Vilagut, Gemma
Ronaldson, Amy
Serrano-Blanco, Antoni
Martín, Vicente
Peters, Michele
Valderas, Jose M
Dregan, Alex
Alonso, Jordi
author_facet Arias-de la Torre, Jorge
Vilagut, Gemma
Ronaldson, Amy
Serrano-Blanco, Antoni
Martín, Vicente
Peters, Michele
Valderas, Jose M
Dregan, Alex
Alonso, Jordi
author_sort Arias-de la Torre, Jorge
title Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
title_short Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
title_full Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
title_fullStr Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
title_full_unstemmed Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
title_sort prevalence and variability of current depressive disorder in 27 european countries: a population-based study
publisher Elsevier, Ltd
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452/
http://www.ncbi.nlm.nih.gov/pubmed/33961802
https://doi.org/10.1016/S2468-2667(21)00047-5
genre Iceland
genre_facet Iceland
op_source Lancet Public Health
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460452/
http://www.ncbi.nlm.nih.gov/pubmed/33961802
http://dx.doi.org/10.1016/S2468-2667(21)00047-5
op_rights © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
op_rightsnorm CC-BY
op_doi https://doi.org/10.1016/S2468-2667(21)00047-5
container_title The Lancet Public Health
container_volume 6
container_issue 10
container_start_page e729
op_container_end_page e738
_version_ 1766043084858064896